AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 162 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $226 | -12.4% | 9,123 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $258 | +22.9% | 9,123 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $210 | -18.0% | 9,123 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $256 | -99.9% | 9,123 | +21.3% | 0.00% | +100.0% |
| Q3 2022 | $213,000 | -37.5% | 7,523 | -35.8% | 0.00% | -50.0% |
| Q1 2022 | $341,000 | -11.4% | 11,723 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $385,000 | -28.8% | 11,723 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $541,000 | -16.3% | 11,723 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $646,000 | -13.3% | 11,723 | -18.7% | 0.00% | -25.0% |
| Q1 2021 | $745,000 | +84.4% | 14,423 | +54.7% | 0.00% | +100.0% |
| Q4 2020 | $404,000 | -89.7% | 9,323 | -91.7% | 0.00% | -93.1% |
| Q3 2020 | $3,910,000 | -70.9% | 111,723 | -55.5% | 0.03% | -49.1% |
| Q2 2020 | $13,426,000 | +367.2% | 251,046 | +209.9% | 0.06% | -8.1% |
| Q1 2020 | $2,874,000 | +7.5% | 81,000 | +44.6% | 0.06% | +34.8% |
| Q4 2019 | $2,674,000 | -47.1% | 56,000 | -64.1% | 0.05% | -54.9% |
| Q3 2019 | $5,054,000 | -45.5% | 156,000 | -16.1% | 0.10% | -40.7% |
| Q2 2019 | $9,278,000 | -26.0% | 186,000 | 0.0% | 0.17% | -29.2% |
| Q1 2019 | $12,544,000 | +39.5% | 186,000 | -4.6% | 0.24% | +34.3% |
| Q4 2018 | $8,991,000 | -66.4% | 195,000 | -43.8% | 0.18% | -45.0% |
| Q3 2018 | $26,760,000 | +95.5% | 347,000 | +113.5% | 0.33% | +22.3% |
| Q2 2018 | $13,687,000 | -22.2% | 162,500 | -24.4% | 0.27% | +47.0% |
| Q1 2018 | $17,582,000 | +215.4% | 215,000 | +120.5% | 0.18% | +177.3% |
| Q4 2017 | $5,574,000 | -14.4% | 97,500 | 0.0% | 0.07% | -19.5% |
| Q3 2017 | $6,508,000 | +23.4% | 97,500 | -4.9% | 0.08% | -39.3% |
| Q2 2017 | $5,274,000 | +351.5% | 102,500 | +412.5% | 0.14% | +321.9% |
| Q1 2017 | $1,168,000 | – | 20,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Ventures 2007 General Partner LLC | 1,930,369 | $118,428,000 | 83.56% |
| Third Rock Ventures, LLC | 3,070,090 | $188,350,000 | 21.97% |
| Opaleye Management Inc. | 113,500 | $6,963,225,000 | 5.43% |
| BB BIOTECH AG | 1,890,521 | $115,983,000 | 4.72% |
| Eventide Asset Management | 431,600 | $26,479,000 | 3.70% |
| Atika Capital Management LLC | 54,000 | $3,313,000 | 2.55% |
| Cormorant Asset Management, LP | 100,000 | $6,135,000 | 1.26% |
| BRIDGER MANAGEMENT, LLC | 220,099 | $13,503,000 | 0.92% |
| Ghost Tree Capital, LLC | 20,000 | $1,227,000 | 0.67% |
| HAMILTON LANE ADVISORS LLC | 27,544 | $1,690,000 | 0.55% |